Browse EX-10 agreements

B Vajdic Performance Award 6.2026

 

CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

HeartBeam, Inc.

2022 Equity Incentive Plan

NOTICE OF RESTRICTED STOCK UNIT AWARD AND

RESTRICTED STOCK UNIT AGREEMENT

 

Capitalized terms that are not defined in this Notice of Restricted Stock Unit Award and Restricted Stock Unit Agreement (the “Notice of Grant”), the Terms and Conditions of Restricted Stock Unit Award, the Non-U.S. Appendix attached hereto as Exhibit B and all other exhibits to these documents (all together, the “Agreement”) have the meanings given to them in the HeartBeam, Inc. 2022 Equity Incentive Plan (the “Plan”).

 

The Participant has been granted this Restricted Stock Unit (“RSU”) award according to the terms below and subject to the terms and conditions of the Plan and this Agreement, as follows:

 

 

Participant

Branislav Vajdic

…

NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON SHARE PURCHASE WARRANT

Genvor Incorporated

 

Warrant Shares: 300,000

 

Date of Issuance: June 17, 2026 (“Issuance Date”)

…

GENVOR INCORPORATED

1550 W Horizon Ridge Pkwy, Ste R #3040

Henderson, NV 89012

 

June 17, 2026

 

Evergreen Capital Management LLC

1412 112th Ave NE, Suite 100 Bellevue, WA 98004

 

Re: Side Letter Agreement Regarding Transaction Documents Dated April 15, 2026

 

Dear Sirs:

 

Reference is hereby made to that certain (i) Securities Purchase Agreement, dated as of April 15, 2026 attached hereto as Exhibit A (the “Original SPA”), by and between Genvor Incorporated, a Nevada corporation (the “Company”) and Evergreen Capital Management LLC, a Nevada limited liability company (“Evergreen”), (ii) the Convertible Promissory Note, dated as of April 15, 2026, of the Company, in the principal amount equal to $800,000 issued by the Company to Evergreen attached hereto as Exhibit B (the “Note”), and (iii) the Common Share Purchase Warrant of the Company dated April 15, 2026 attached hereto as Exhibit C (the “Warrant”). Capitalized terms used but not defined herein shall have the meanings given to them in the Original SPA, or if not defined therein, in the Note.

…

Employment Agreement

This Employment Agreement, is entered into on June 18th, 2026 by and between

 

DEEL INNOVATION LTD., an Israeli company registered under number 515701910, with its registered office at 103 Hahashmonaim, Tel Aviv, Israel (the “Company”).

 

and

 

Gil Issachar, with residence at 7 HaHumash St., Hod-Hasharon, 4501870, IL , with a personal ID number of                        (the “Employee”).

 

WHEREAS:

 

1. The Company and the Employee are willing to enter into an employment relationship ;

2. The Company and the Employee wish to clarify certain obligations and rights in respect of said employment relationship;

…

SECURITIES PURCHASE AGREEMENT

 

 

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of June 15, 2026, by and between Cheetah Net Supply Chain Service Inc., a Delaware corporation (Nasdaq: CTNT) (the “Company”), and Huan Liu, an individual, solely in his individual capacity and not in his capacity as an officer or director of the Company (the “Purchaser”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, the “Shares”), at a purchase price of $2.00 per Share, for an aggregate purchase price of $ 400,000.

 

WHEREAS, the Purchaser is the Chief Executive Officer, Director and Chairman of the Board of Directors of the Company, and the Board of Directors of the Company, acting through a committee of disinterested directors, has reviewed and approved the transactions contemplated hereby as a related-party transaction.

…

[DEALER]1

[______], 2026

 

To:

Adaptive Biotechnologies Corporation

1165 Eastlake Avenue East

Seattle, Washington 98109

Re: [Base][Additional] Call Option Transaction

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [DEALER] (“Dealer”) andAdaptive Biotechnologies Corporation (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Counterparty and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

…

WAIVER AGREEMENT

This WAIVER AGREEMENT (this “Waiver”) is entered into as of June 15, 2026, by and among Adaptive Biotechnologies Corporation, a Washington corporation (the “Company”), OrbiMed Royalty & Credit Opportunities IV, LP, a Delaware limited partnership, in its capacity as Purchaser Agent and as a Purchaser (in such capacities, “OrbiMed”), and each other Purchaser party hereto (OrbiMed, together with such other Purchasers, the “Waiving Parties”).

RECITALS

A. The Company, OrbiMed (as Purchaser Agent) and the Purchasers are parties to that certain Revenue Interest Purchase Agreement, dated as of September 12, 2022 (as amended, supplemented or otherwise modified from time to time, the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.

…

FOURTH AMENDMENT TO THIRD AMENDED AND RESTATED LOAN AGREEMENT

 

This Fourth Amendment to Third Amended and Restated Loan Agreement (this “Amendment”) is made as of June 18, 2026, by and between Cohen & Company Securities, LLC, f/k/a J.V.B. Financial Group, LLC, a Delaware limited liability company (“Broker/Dealer”), and Byline Bank (“Lender”), with reference to the following facts:

 

A.            Pursuant to the terms and conditions of that certain Third Amended and Restated Loan Agreement, dated as of June 9, 2023, as amended by that certain First Amendment to Third Amended and Restated Loan Agreement, dated as of December 22, 2023, and effective as of December 21, 2023, that certain Second Amendment to Third Amended and Restated Loan Agreement, dated June 18, 2024, and that certain Third Amendment to Third Amended and Restated Loan Agreement, dated June 20, 2025, and effective as of June 18, 2025 (the “Loan Agreement”) by and between Broker/Dealer and Lender, Lender agreed to make a revolving loan commitment to Broker/Dealer in the principal amount of Fift

…

AMENDMENT NO. 2 TO THE

STAAR SURGICAL COMPANY

AMENDED AND RESTATED OMNIBUS EQUITY INCENTIVE PLAN

This Amendment No. 2 (the “Amendment No. 2”) to the STAAR Surgical Company Amended and Restated Omnibus Equity Incentive Plan (the “Plan”) is adopted by the Board of Directors (“Board”) of STAAR Surgical Company, a Delaware corporation (the “Company”) on April 15, 2026. This Amendment No. 2 will become effective upon approval by the Company’s shareholders at the Company’s 2026 annual meeting of shareholders.

WHEREAS, the Plan was last approved by the Company’s shareholders on June 15, 2023; and

WHEREAS, the shareholders approved Amendment No. 1 to the Plan on June 20, 2024; and

WHEREAS, the Board desires to further amend the Plan pursuant to this Amendment No. 2, subject to approval of the Company’s shareholders, to increase the number of shares of Company common stock available for issuance thereunder; and

WHEREAS, if the Company’s shareholders fail to approve this Amendment No. 2, the existing Plan, as amended by Amendment No. 1, shall continue in full force and effect.

…

ORIC PHARMACEUTICALS, INC.

2020 EQUITY INCENTIVE PLAN

(as amended and restated effective as of June 18, 2026)

 

 

Purposes of the Plan. The purposes of this Plan are:

 

 

•

 

to attract and retain the best available personnel for positions of substantial responsibility,

 

 

•

 

to provide additional incentive to Employees, Directors and Consultants, and

 

 

•

 

to promote the success of the Company’s business.

The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares.

 

 

Definitions. As used herein, the following definitions will apply:

(a) “Administrator” means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.

…

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of June 19, 2026 by and between Domino’s Pizza, Inc., a Delaware corporation (the “Company”), and Joseph H. Jordan (the “Executive”), and is effective as of 12:00 a.m. ET on October 1, 2026 (the “Effective Date”).

WHEREAS, the Executive possesses certain experience and expertise that qualifies him to provide the direction and leadership required by the Company; and

WHEREAS, the Company desires to employ the Executive as Chief Executive Officer of the Company and the Executive wishes to accept such employment.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and intending to be legally bound hereby, the Company and the Executive agree as follows:

1. Position and Duties.

…

June 19, 2026

Mr. Russell J. Weiner

 

Re:

Letter Agreement

Dear Mr. Weiner,

Reference is made to the amended and restated employment agreement by and among you and Domino’s Pizza, Inc., a Delaware corporation (the “Company”), and Domino’s Pizza LLC, a Michigan limited liability company, effective as of May 1, 2022 (the “Employment Agreement”). Capitalized terms not defined in this letter agreement have the meanings given to them in the Employment Agreement. Subject to earlier termination as provided therein, your employment with the Company under the Employment Agreement will continue until 11:59 p.m. ET on September 30, 2026. By entering into this letter agreement with the Company (the “Letter Agreement”), and provided your employment with the Company has not earlier terminated, you agree that your employment with the Company will continue without interruption under the terms and conditions of this Letter Agreement, effective as of 12:00 a.m. ET on October 1, 2026 (the “Effective Date”), as follows:

 

 

…